MLL Gene Rearranged Acute Lymphoblastic Leukemia

被引：0
|
作者：
Pieters, Rob [1 ]
机构：
[1] Princess Maxima Ctr Pediat Oncol, NL-3584 CS Utrecht, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
MLL gene; Nucleoside; Stem cell transplantation; RAS mutations; Epigenetics; STEM-CELL TRANSPLANTATION; CHILDRENS ONCOLOGY GROUP; THERAPEUTIC TARGET; FLT3; EXPRESSION; INFANT; INHIBITION; CHEMOTHERAPY; INTERFANT-99; PROFILE; ABSENCE;
D O I：
10.1016/j.clml.2018.06.053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TH-S18-ALL
引用
收藏
页码：S48 / S50
页数：3
相关论文
共 50 条
  • [31] Unusual profiles of pediatric acute lymphoblastic leukemia with MLL gene rearrangement
    Kubicka, Malgorzata
    Soszynska, Krystyna
    Mucha, Barbara
    Rafinska, Beata
    Kolodziej, Beata
    Haus, Olga
    Styczynski, Jan
    LEUKEMIA & LYMPHOMA, 2007, 48 (10) : 2083 - 2086
  • [32] 5′ MLL Gene Deletion in a Case with Childhood Acute Lymphoblastic Leukemia
    Gulten, Tuna
    Yakut, Tahsin
    Gunes, Adalet Meral
    Demirkaya, Metin
    LABMEDICINE, 2010, 41 (02): : 83 - 86
  • [33] MLL gene in maternal and infantile acute lymphoblastic leukemia and the effect of Estrogen
    Aljurf, Mahmoud
    Saleh, A. J. M.
    Ahmed, Syed Osman
    LEUKEMIA RESEARCH, 2011, 35 (07) : E127 - E127
  • [34] Minimal Residual Disease Monitoring by Quantification of Fusion Gene Transcripts In Infant with MLL-rearranged Acute Lymphoblastic Leukemia Treated by MLL-Baby Protocol
    Tsaur, Grigory
    Popov, Alexander
    Nasedkina, Tatyana
    Kalennik, Olga
    Kustanovich, Anatoly
    Aleinikova, Olga
    Riger, Tatyana
    Yakovleva, Yulia
    Iyanova, Anna
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    BLOOD, 2010, 116 (21) : 1126 - 1126
  • [35] Bet Inhibition as a Novel Therapeutic Approach for the Treatment of MLL-Rearranged Acute Lymphoblastic Leukemia in Infants
    Bardini, M.
    Trentin, L.
    Rizzo, F.
    Vieri, M.
    Savino, A. M.
    Fazio, G.
    Geertruy, T. K.
    Basso, G.
    Cazzaniga, G.
    Biondi, A.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S101 - S101
  • [36] PREDICTION OF OUTCOME IN INFANTS WITH MLL-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA BY TIME TO ACHIEVEMENT OF MOLECULAR REMISSION
    Tsaur, Grigory
    Nasedkina, Tatyana
    Ivanova, Anna
    Yakovleva, Yulia
    Riger, Tatyana
    Popov, Alexander
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 777 - 777
  • [37] NF-κB activation mediates resistance to IFNβ in MLL-rearranged acute lymphoblastic leukemia
    L Tracey
    C J Streck
    Z Du
    R F Williams
    L M Pfeffer
    A C Nathwani
    A M Davidoff
    Leukemia, 2010, 24 : 806 - 812
  • [38] Methionine Restriction As a Novel Therapeutic Strategy for MLL (KMT2A)Rearranged Acute Lymphoblastic Leukemia
    Tee, Trisha
    Riter, Titine
    Dhaoui, Ahmed
    Schenau, Dorettevan Ingen
    Hagelaar, Rico
    der Meer, Laurensvan
    Leeuwen, Frankvan
    BLOOD, 2021, 138
  • [39] NF-κB activation mediates resistance to IFNβ in MLL-rearranged acute lymphoblastic leukemia
    Tracey, L.
    Streck, C. J.
    Du, Z.
    Williams, R. F.
    Pfeffer, L. M.
    Nathwani, A. C.
    Davidoff, A. M.
    LEUKEMIA, 2010, 24 (04) : 806 - 812
  • [40] Bispecific CAR-iNKT Immunotherapy for High Risk MLL- Rearranged Acute Lymphoblastic Leukemia
    Ren, Hongwei
    Elliott, Natalina
    Phil, Bryan Lye M.
    Cross, Joe
    Field, Lucy
    Ponnusamy, Kanagaraju
    Roberts, Irene
    Halsey, Christina
    Milne, Thomas Arthur
    Roy, Anindita
    Karadimitris, Anastasios
    BLOOD, 2023, 142
12345